智通财经APP讯，金斯瑞生物科技(01548)发布公告，柳振宇已提交辞呈，因其个人职业发展相关原因辞去公司轮值首席执行官、公司制裁风险控制委员会成员及公司全资附属公司CustomArray Inc.董事，于2024年12月31日生效。其亦已提交辞呈辞去公司非全资附属公司Probio Technology Limited董事会主席职务，于2024年12月1日生效。
邵炜慧仍担任公司轮值首席执行官。公司的执行董事兼首席战略官朱力已获委任为Probio Technology Limited董事会主席，自2024年12月1日起生效。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.